Friday, March 8, 2019
The US Opioid Crisis and Breast Cancer Patrick I. Borgen, MD
TAILORx and the De-escalation of Therapy Joseph A. Sparano, MD
Nontraditional Genetic Counseling: Solving the Challenge of the Undetected Carrier Pat W. Whitworth, MD
CDK4/6 Inhibitors - Where Are We, and What’s Next? Debu Tripathy, MD
Update From ESMO: Immunotherapy in Breast Cancer Elizabeth Mittendorf, MD, PhD, & Hope S. Rugo, MD, FASCO
Saturday, March 9, 2019
State-of-the-Art Approach to MRI in Breast Cancer Elizabeth Morris, MD, FACR, FSBI, FISMRM
Controversies in the Optimal Management of HER2+ Breast Cancer Mark D. Pegram, MD
Surgery for the Primary in De Novo Stage IV Disease Tari A. King, MD
Breast Cancer in Pregnancy and in Younger Women Ann H. Partridge, MD, MPH
Medical Crossfire®: Optimal De-escalation in Patients Undergoing BCT for pN0 Breast Cancer: PBI or Omission? Patrick I. Borgen, MD; Reshma Jagsi, MD, DPhil; and Frank A. Vicini, MD, FACR, FABS, FASTRO;
Keynote Address Gregory Stock, PhD
Sunday, March 10, 2019
Rare Breast Cancers David M. Euhus, MD, FACS
Physician Burnout: An Action-Oriented Roundtable Discussion Patrick I. Borgen, MD; Anees B. Chagpar, MD, MSc, MPH, MA, MBA, FACS, FRCSC; Kelly K. Hunt, MD; and, Pat W. Whitworth, MD
The Art and Science of Survivorship Planning and Management Ann H. Partridge, MD, MPH